Literature DB >> 22971326

Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012.

A Meijer1, M Jonges, P van Beek, C M Swaan, A D Osterhaus, R S Daniels, A C Hurt, M P Koopmans.   

Abstract

Two Dutch travellers were infected with oseltamivir-resistant influenza A(H1N1)pdm09 viruses with an H275Y neuraminidase substitution in early August 2012. Both cases were probably infected during separate holidays at the Catalonian coast (Spain). No epidemiological connection between the two cases was found, and neither of them was treated with oseltamivir before specimen collection. Genetic analysis of the neuraminidase gene revealed the presence of previously described permissive mutations that may increase the likelihood of such strains emerging and spreading widely.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22971326

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  15 in total

1.  Data-driven interdisciplinary mathematical modelling quantitatively unveils competition dynamics of co-circulating influenza strains.

Authors:  Bin-Shenq Ho; Kun-Mao Chao
Journal:  J Transl Med       Date:  2017-07-28       Impact factor: 5.531

2.  Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses.

Authors:  Henju Marjuki; Vasiliy P Mishin; Anton P Chesnokov; Juan A De La Cruz; Charles T Davis; Julie M Villanueva; Alicia M Fry; Larisa V Gubareva
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

3.  Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.

Authors:  A Kossyvakis; A-F A Mentis; K Tryfinopoulou; V Pogka; A Kalliaropoulos; E Antalis; T Lytras; A Meijer; S Tsiodras; P Karakitsos; A F Mentis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-15       Impact factor: 3.267

4.  Evolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice.

Authors:  Andrés Pizzorno; Yacine Abed; Pier-Luc Plante; Julie Carbonneau; Mariana Baz; Marie-Ève Hamelin; Jacques Corbeil; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2014-08-11       Impact factor: 5.191

5.  Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets.

Authors:  Yacine Abed; Andrés Pizzorno; Xavier Bouhy; Chantal Rhéaume; Guy Boivin
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

Review 6.  Detection and management of antiviral resistance for influenza viruses.

Authors:  Guy Boivin
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380

Review 7.  A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade.

Authors:  Ding Yuan Oh; Aeron C Hurt
Journal:  Scientifica (Cairo)       Date:  2014-04-02

8.  Oseltamivir-resistant influenza A(H1N1)pdm09 viruses, United States, 2013-14.

Authors:  Margaret Okomo-Adhiambo; Alicia M Fry; Su Su; Ha T Nguyen; Anwar Abd Elal; Elizabeth Negron; Julie Hand; Rebecca J Garten; John Barnes; Xu Xiyan; Julie M Villanueva; Larisa V Gubareva
Journal:  Emerg Infect Dis       Date:  2015-01       Impact factor: 6.883

9.  Characterization of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post-pandemic periods in Japan.

Authors:  Emi Takashita; Seiichiro Fujisaki; Noriko Kishida; Hong Xu; Masaki Imai; Masato Tashiro; Takato Odagiri
Journal:  Influenza Other Respir Viruses       Date:  2013-06-08       Impact factor: 4.380

10.  Model-based simulation and prediction of an antiviral strategy against influenza A infection.

Authors:  Kye-Yeon Hur; Joon-Young Moon; Seung-Hwan Kim; Joo-Yeon Yoo
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.